Concurrent Chemo-Radiotherapy for Limited Small Cell Carcinoma of the Lung OPENED GROUPWIDE: 3/22/85

Southwest Oncology Group: Two decades of experience in non-small cell lung cancer

AT Turrisi;J Crowley;K Albain;L Gaspar;D Gandara Seminars in Oncology 32(2Suppl3):S119-S121

PMid: PMID16015548

Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer

CR Thomas;DJ Giroux;LM Janaki;AT Turrisi;JJ Crowley;SA Taylor;JD McCracken;PGS Giri;W Gordon;RB Livingston;DR Gandara Lung Cancer 33:213-219

Ten-year follow-up of SWOG 8269: a phase 2 trial of concomitant cisplatin-etoposide (PE) and daily thoracic radiotherapy (TRT) in limited small cell lung cancer (L-SCLC)

CR Thomas;DJ Giroux;LM Janaki;AT Turrisi;JJ Crowley;JD McCracken;RB Livingston;DR Gandara Radiology 217Suppl:261(#251)

Patterns of failure and second malignancies from SWOG-8269: Concurrent cisplatin (P), etoposide (E), vincristine (V), and once daily radiotherapy (RT) for the treatment of limited small-cell lung cancer (SCLC).

L Janaki;D Rector;A Turrisi;J McCracken;R Livingston;S Giri;W Gordon;J Crowley ASCO 13:331(#1096)

Long term follow-up (F/U) from SWOG 8269: Concurrent cisplatin (P), etoposide (E), vincristine (V) and daily radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): Patterns of failure and second tumors.

A Turrisi;D Rector;LM Janaki;JD McCracken;R Livingston;SP Giri;W Gordon;J Crowley Lung Cancer 11(Suppl.1):172(#666)

Concurrent chemotherapy/radiotherapy for limited small cell lung carcinoma: A Southwest Oncology Group study.

JD McCracken;LM Janaki;JJ Crowley;SA Taylor;PGS Giri;GB Weiss;W Gordon;LH Baker;A Mansouri;JP Kuebler JCO 8(5):892-898

Determinants of improved outcome in small cell lung cancer: An analysis of 2,580-patient Southwest Oncology Group data base.

KS Albain;JJ Crowley;M LeBlanc;RB Livingston JCO 8(9):1563-1574

Concurrent chemoradiotherapy for limited small cell carcinoma ofthe lung (SCCL).

JD McCracken;L Janaki;SA Taylor;GB Weiss;J Crowley ASCO :#C-656

Concommitant chemo radiotherapy in limited small cell carcinomaof lung: Improved response and median survival. A Southwest OncologyGroup Study.

LM Janaki;JD McCracken;SB Taylor;PGS Giri;GB Weiss;W Gordon, Jr;RB Vance;J Crowley Presented at the 29th Annual ASTRO Meeting in Boston October 18-23

Concurrent chemoradiotherapy for limited small cell carcinoma of the lung (SCCL). A Southwest Oncology Group limited institutional pilot study.

JD McCracken;L Janaki;SA Taylor;GB Weiss ASCO, #C-683